The report on global transdermal drug delivery system market is an in depth analysis of the segments and sub-segments in the transdermal drug delivery system market. The report provides analysis for the global as well as regional markets over the period of 2015 to 2023. According to report the global transdermal drug delivery system market is expected to grow at a CAGR of 9.3% over the forecast period of 2017 - 2023.

Figure 1: Global Transdermal Drug Delivery System Market by Value 2015 - 2023

Segments Covered

The report on global transdermal drug delivery system market covers segments such as product, technology, applicationand facility of use. The product segments include gel and patches. On the basis of technology, the global transdermal drug delivery system market is categorized into radio frequency, mechanical arrays, electroporation, ultrasound, electric current, microporation, lontophoresis, thermal and others. Furthermore, on the basis of application the transdermal drug delivery system market is segmented as cardiovascular disease, central nervous system disorders, hormonal diseases, pain management and others. On the basis of facility of use the transdermal drug delivery system market is segmented as hospitals and private clinics, homecare settings, surgical centers and others.

Geographic Coverage

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.

Figure 2: Global Transdermal Drug Delivery System Market by Region, CAGR %, 2015-2023

The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.

Companies Profiled:

The report provides profiles of the companies in the global transdermal drug delivery system market such as, Watson Pharmaceuticals, Inc, Noven Pharmaceuticals, Inc, Novartis AG, Biogel Technology, Inc, Crescita Therapeutics Inc, Echo Therapeutics Inc, 3M Drug Delivery Systems, Transdermal Corp, Skyepharma PLC, and Pantec Biosolutions AG.

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global transdermal drug delivery system market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider.

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of transdermal drug delivery system market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the transdermal drug delivery system market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.

This report will help manufacturers, suppliers and distributors of the transdermal drug delivery system market to understand the present and future trends in this market and formulate their strategies accordingly.